About Project ECHO
Project ECHO® Ontario: Epilepsy Across the Lifespan is a technology-enabled, collaborative, accredited learning program that partners community health care providers and epilepsy specialists to enhance care for children, adolescents and adults living with epilepsy.
Recognizing limited access to neurology and other specialties, which support this often complex population, our epilepsy interdisciplinary team connects with providers in communities across Ontario via one-to-many videoconferencing for 90-minute “TeleECHO® sessions”, twice monthly. Sessions can be accessed from a smart device or laptop from anywhere with an internet connection. The format of the TeleECHO® session leverages interactive case-based learning followed. Through sharing evidence-informed knowledge an actionable care plan for patients are developed. The session closes with a quick 15 – 20 minute didactic talk delivering relevant clinical pearls on a topic of interest.
Project ECHO Host Sites:
The Project ECHO epilepsy interdisciplinary teams are based in 10 programs across the Province. Each team includes an epileptologist, nurse practitioner, pharmacist, social worker and community agency representative connected with Ontario’s regional Comprehensive Epilepsy Programs (CEPs). Ontario’s CEPs are located in:
- Hamilton: Hamilton Health Sciences and McMaster Children’s Hospital
- Kingston: Kingston General Hospital
- London: London Health Sciences Centre and the Children’s Hospital
- Ottawa: The Ottawa Hospital and the Children’s Hospital of Eastern Ontario
- Thunder Bay: Thunder Bay Regional Health Sciences Centre
- Toronto: Hospital for Sick Children and University Health Network (TWH site)
About Epilepsy in Ontario
Epilepsy is second only to headache among common neurological conditions in Ontario, but the burden of illness of epilepsy is far greater. Epilepsy impacts approximately 90,000 Ontarians and 6,000 new cases of epilepsy diagnosed each year. Epilepsy can have a significant impact on quality of life. People with epilepsy are 71% more likely to have a concurrent mental health disorder in their lifetime. Many individuals with epilepsy, when diagnosed appropriately, can be treated effectively with antiepileptic drugs. An estimated 30% have drug-resistant epilepsy, experiencing seizures that do not respond to treatment with two or more appropriate trials of antiepileptic drug therapy. Other treatment options include surgery, diet therapy and neurostimulation.